An on-demand presentation by Soichi Utsami, General Manager of Sales, Japan, Ajinomoto Bio-Pharma Services
With over 20 years of oligonucleotide CDMO experience, Ajinomoto Bio-Pharma Services is a premier provider of high quality, scalable custom oligonucleotides.
We offer the capacity and quality to scale your process through clinical development and commercialization, and our service offerings have been designed to meet the current and future needs of our clients in order to ensure a stable supply and seamless scale up of your promising therapeutics.
In this webinar, Soichi Utsumi, General Manager of Sales at Aji Bio-Pharma Osaka, introduces our oligo capabilities and novel technologies.
Find out more at ajibio-pharma.com.